Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for Treatment of Covid-19 Patients
NCT04370288Phase 1Unknown
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of methylene blue in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Proportion of patients remaining free of need for mechanical ventilation at 7 days. Status: unknown.
02
Drugs
methylene blue
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04370288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04370288.